{"id":"bilirubin","rwe":[{"pmid":"41909880","year":"2025","title":"Low incidence of cytolysin-positive E. faecalis and no correlation to survival in Danish patients with alcohol-associated hepatitis: A prospective cohort study.","finding":"","journal":"Gut microbes reports","studyType":"Clinical Study"},{"pmid":"41909607","year":"2026","title":"Prognostic Outcomes by Ishak Fibrosis Score Grouping in Biliary Atresia After Kasai Surgery.","finding":"","journal":"International journal of general medicine","studyType":"Clinical Study"},{"pmid":"41909593","year":"2026","title":"Development and Validation of an Explainable Machine Learning Model for Predicting Repeat Catheter Ablation for Atrial Fibrillation: A Single-Center Retrospective Cohort Study.","finding":"","journal":"International journal of general medicine","studyType":"Clinical Study"},{"pmid":"41908670","year":"2026","title":"Prognostic Significance of Serum Ferritin in Decompensated Cirrhosis: Insights from a Prospective Analysis.","finding":"","journal":"Journal of clinical and experimental hepatology","studyType":"Clinical Study"},{"pmid":"41908015","year":"2025","title":"Effect of dexmedetomidine, lignocaine and combination infusion for postoperative outcomes in abdominal surgery.","finding":"","journal":"Bioinformation","studyType":"Clinical Study"}],"_fda":{"id":"9cfee475-afb6-479b-a552-240f97fb29a7","set_id":"20e20965-61db-44a3-82bf-f1ca18e6b6bc","openfda":{"unii":["2P3VWU3H10","6T6CO7R3Z5","28M1820ACT","1TH8Q20J0U","RFM9X3LJ49","279O8I0433","MU72812GK0","AYI8EX34EU","4VBP01X99F","P776JQ4R2F","8724FJW4M5","DJO934BRBD","324Y4038G2","2S713A4VP3","C177VR41DV","G025DAL7CE","Y3V16D4PV4","H6241UJ22B","9W945B5H7R","WYT05213GE","S61JFZ33Z1","39981FM375","QNS6W5US1Z"],"route":["ORAL"],"spl_id":["9cfee475-afb6-479b-a552-240f97fb29a7"],"brand_name":["Colotox"],"spl_set_id":["20e20965-61db-44a3-82bf-f1ca18e6b6bc"],"package_ndc":["43857-0801-1"],"product_ndc":["43857-0801"],"generic_name":["ALFALFA, BERBERIS VULGARIS, RHAMNUS PURSHIANA, RHEUM (PALMATUM), TARAXACUM OFFICINALE, HEPAR BOVINE, SMALL INTESTINE (SUIS), ARANEA DIADEMA, CARBO ANIMALIS, CARBO VEGETABILIS, CINA, MERCURIUS SOLUBILIS, PODOPHYLLUM PELTATUM, SELENIUM METALLICUM, SPIGELIA ANTHELMIA, VERATRUM ALBUM, BILIRUBIN, CREATINE, CREATININE, INDOLUM, SKATOLUM, PROTEUS (MIRABILIS), MORGAN GAERTNER"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ACTIVATED CHARCOAL","ARANEUS DIADEMATUS","ARTEMISIA CINA PRE-FLOWERING TOP","BERBERIS VULGARIS ROOT BARK","BILIRUBIN","CARBO ANIMALIS","CREATINE","CREATININE","FRANGULA PURSHIANA BARK","HEPARIN, BOVINE","INDOLE","MEDICAGO SATIVA WHOLE","MERCURIUS SOLUBILIS","PODOPHYLLUM","PROTEUS MIRABILIS","RHEUM PALMATUM ROOT","SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS","SELENIUM","SKATOLE","SPIGELIA ANTHELMIA WHOLE","SUS SCROFA INTESTINAL MUCOSA","TARAXACUM OFFICINALE","VERATRUM ALBUM ROOT"],"manufacturer_name":["BioActive Nutritional, Inc."],"is_original_packager":[true]},"purpose":["PURPOSE: For temporary relief of flatulence associated with constipation."],"version":"1","warnings":["WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in cool, dry place."],"questions":["QUESTIONS: Distributed by: BioActive Nutritional, Inc. 1803 N. Wickham Rd. Melbourne, FL 32935 bioactivenutritional.com"],"effective_time":"20260120","active_ingredient":["ACTIVE INGREDIENTS: Alfalfa 3X, Berberis Vulgaris 3X, Rhamnus Purshiana 3X, Rheum 3X, Taraxacum Officinale 3X, Hepar Bovine 8X, Small Intestine 8X, Aranea Diadema 12X, Carbo Animalis 12X, Carbo Vegetabilis 12X, CINA 12X, Mercurius Solubilis 12X, Podophyllum Peltatum 12X, Selenium Metallicum 12X, Spigelia Anthelmia 12X, Veratrum Album 12X, Bilirubin 15X, 30X, 200X, Creatine 15X, 30X, 200X, Creatinine 15X, 30X, 200X, Indolum 15X, 30X, 200X, Skatolum 15X, 30X, 200X, Proteus 20X, Morgan Gaertner 12C."],"inactive_ingredient":["INACTIVE INGREDIENTS: Demineralized Water, 25% Ethanol"],"indications_and_usage":["INDICATIONS: For temporary relief of flatulence associated with constipation."],"dosage_and_administration":["DIRECTIONS: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Colotox Alfalfa, Berberis Vulgaris, Rhamnus Purshiana, Rheum (Palmatum), Taraxacum Officinale, Hepar Bovine, Small Intestine (Suis), Aranea Diadema, Carbo Animalis, Carbo Vegetabilis, CINA, Mercurius Solubilis, Podophyllum Peltatum, Selenium Metallicum, Spigelia Anthelmia, Veratrum Album, Bilirubin, Creatine, Creatinine, Indolum, Skatolum, Proteus (Mirabilis), Morgan Gaertner MEDICAGO SATIVA WHOLE ALFALFA BERBERIS VULGARIS ROOT BARK BERBERIS VULGARIS ROOT BARK FRANGULA PURSHIANA BARK FRANGULA PURSHIANA BARK RHEUM PALMATUM ROOT RHEUM PALMATUM ROOT TARAXACUM OFFICINALE TARAXACUM OFFICINALE HEPARIN, BOVINE HEPARIN, BOVINE SUS SCROFA INTESTINAL MUCOSA SUS SCROFA INTESTINAL MUCOSA ARANEUS DIADEMATUS ARANEUS DIADEMATUS CARBO ANIMALIS CARBO ANIMALIS ACTIVATED CHARCOAL ACTIVATED CHARCOAL ARTEMISIA CINA PRE-FLOWERING TOP ARTEMISIA CINA FLOWER MERCURIUS SOLUBILIS MERCURIUS SOLUBILIS PODOPHYLLUM PODOPHYLLUM SELENIUM SELENIUM SPIGELIA ANTHELMIA WHOLE SPIGELIA ANTHELMIA VERATRUM ALBUM ROOT VERATRUM ALBUM ROOT BILIRUBIN BILIRUBIN CREATINE CREATINE CREATININE CREATININE INDOLE INDOLE SKATOLE SKATOLE PROTEUS MIRABILIS PROTEUS MIRABILIS SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: Bio Active Nutritional COLOTOX HOMEOPATHIC 1 FL OZ (30 ml) image description"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Active","category":"status"},{"label":"flatulence associated with constipation","category":"indication"},{"label":"BioActive Nutritional, Inc.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[]},"trials":[],"aliases":[],"company":"BioActive Nutritional, Inc.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=BILIRUBIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:30:06.155437+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:30:12.375556+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BILIRUBIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:30:12.698978+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:05.030368+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:05.030403+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2074720/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:30:13.403850+00:00"}},"allNames":"colotox","offLabel":[],"synonyms":["Colotox","ACTIVATED CHARCOAL"],"timeline":[],"approvals":[],"brandName":"Colotox","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Colotox, a small molecule, is believed to exert its effects by inhibiting the activity of gut bacteria, specifically those involved in the breakdown of complex carbohydrates, thereby reducing the production of short-chain fatty acids and subsequent gas production."},"commercial":{},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"BILIRUBIN\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=bilirubin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=bilirubin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:34:11.007971","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:30:15.322973+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"bilirubin","indications":{"approved":[{"name":"flatulence associated with constipation","source":"OpenFDA Label","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06018831","phase":"NA","title":"Urine and Ultrasound Screening for Kidney Disease in Children","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-04-12","conditions":["Kidney Diseases","Diagnostic Techniques","Ultrasound","Urinalysis","Child, Only"],"enrollment":13000,"completionDate":"2028-02"},{"nctId":"NCT05848310","phase":"","title":"Preoperative Serum FGF19 in the Prognosis of Biliary Atresia","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-10-15","conditions":["Biliary Atresia","Prognosis"],"enrollment":200,"completionDate":"2027-08"},{"nctId":"NCT03741803","phase":"NA","title":"Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-11-09","conditions":["Hyperbilirubinemia, Neonatal","Jaundice, Neonatal"],"enrollment":20,"completionDate":"2019-05-27"},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":["Primary Sclerosing Cholangitis (PSC)","Inflammatory Bowel Disease (IBD)"],"enrollment":72,"completionDate":"2030-05"},{"nctId":"NCT00044304","phase":"PHASE2","title":"Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-09-26","conditions":["Eosinophilic Myeloid Neoplasm","Hypereosinophilic Syndrome"],"enrollment":70,"completionDate":"2027-03-10"},{"nctId":"NCT04953910","phase":"PHASE1","title":"Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment","status":"RECRUITING","sponsor":"Taiho Oncology, Inc.","startDate":"2022-12-23","conditions":["Acute Myeloid Leukemia","Myelodysplastic Syndromes"],"enrollment":27,"completionDate":"2026-12"},{"nctId":"NCT06260566","phase":"PHASE1","title":"Tolerability of Enteral NAC in Infants","status":"NOT_YET_RECRUITING","sponsor":"Sanjiv Harpavat","startDate":"2026-10","conditions":["Biliary Atresia"],"enrollment":12,"completionDate":"2031-10"},{"nctId":"NCT06561477","phase":"","title":"Role of ICCO Score in Predicting Outcome in ICU Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2025-03-01","conditions":["Liver Cirrhosis"],"enrollment":150,"completionDate":"2026-02-06"},{"nctId":"NCT07250854","phase":"EARLY_PHASE1","title":"The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-01-23","conditions":["Biliary Atresia","Kasai","Cholestasis in Newborn","Cholestasis in Newborn Infant"],"enrollment":15,"completionDate":"2027-03"},{"nctId":"NCT05572944","phase":"","title":"Formatting the Risk Prediction Models for Never-Smoking Lung Cancer","status":"RECRUITING","sponsor":"Chung Shan Medical University","startDate":"2022-12-15","conditions":["Lung Cancer"],"enrollment":10000,"completionDate":"2029-12-31"},{"nctId":"NCT05442749","phase":"PHASE2","title":"Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer","status":"TERMINATED","sponsor":"Centre Leon Berard","startDate":"2022-10-28","conditions":["Metastatic Pancreatic Cancer"],"enrollment":2,"completionDate":"2024-08-30"},{"nctId":"NCT07409194","phase":"NA","title":"The Effect of Acupressure on Hyperbilirubinemia in Newborns: A Randomized Controlled Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Yuzuncu Yil University","startDate":"2025-05-05","conditions":["Hyperbilirubinemia"],"enrollment":60,"completionDate":"2026-05-05"},{"nctId":"NCT04316650","phase":"NA","title":"Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06","conditions":["Paraphilia"],"enrollment":0,"completionDate":"2027-10"},{"nctId":"NCT07397689","phase":"","title":"Early Sepsis Recognition Tool","status":"NOT_YET_RECRUITING","sponsor":"KK Women's and Children's Hospital","startDate":"2026-02","conditions":["Infection","Sepsis"],"enrollment":40000,"completionDate":"2028-12"},{"nctId":"NCT05582447","phase":"","title":"Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-04-17","conditions":["Cholestasis","Red Cell Membrane and Enzyme Abnormalities"],"enrollment":40,"completionDate":"2027-12-31"},{"nctId":"NCT02967848","phase":"","title":"Liver Function Investigation With SPECT","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal North Shore Hospital","startDate":"2016-10-19","conditions":["Liver Cancer, Adult"],"enrollment":20,"completionDate":"2026-12-31"},{"nctId":"NCT07388732","phase":"NA","title":"The Effect of Abdominal Massage on Jaundice and Defecation in Newborn Babies","status":"COMPLETED","sponsor":"Kutahya Health Sciences University","startDate":"2020-02-29","conditions":["Hyper Bilirubinemia","Phototherapy","Jaundice, Neonatal"],"enrollment":35,"completionDate":"2025-01-14"},{"nctId":"NCT07215273","phase":"PHASE2","title":"Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections","status":"RECRUITING","sponsor":"Elion Therapeutics, Inc.","startDate":"2026-02","conditions":["Suspected Invasive Mould Infection"],"enrollment":80,"completionDate":"2026-11"},{"nctId":"NCT06126601","phase":"","title":"Incidence and Clinical Impact of Serum Hyperamylasemia (POH) After Pancreatectomy on Postoperative Outcome and Patient Safety","status":"RECRUITING","sponsor":"Technische Universität Dresden","startDate":"2023-07-18","conditions":["Pancreatectomy","Hyperamylasemia","Pancreatitis, Acute"],"enrollment":150,"completionDate":"2026-07"},{"nctId":"NCT07377786","phase":"","title":"Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-02-01","conditions":["HELLP Syndrome"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT07023354","phase":"PHASE1","title":"A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-06-25","conditions":["Healthy","Hepatic Impairment"],"enrollment":32,"completionDate":"2026-07-04"},{"nctId":"NCT04680728","phase":"","title":"Venous Congestion and Organ Dysfunction.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-10-06","conditions":["Venous Congestion","Organ Dysfunction Syndrome"],"enrollment":185,"completionDate":"2022-11-14"},{"nctId":"NCT06114498","phase":"","title":"Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Medical Research Center for Therapy and Preventive Medicine","startDate":"2023-09-01","conditions":["Heart Failure With Preserved Ejection Fraction","Obesity, Mild","Decompensated Heart Failure"],"enrollment":240,"completionDate":"2026-07-31"},{"nctId":"NCT06832800","phase":"EARLY_PHASE1","title":"Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH","status":"RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2025-07-21","conditions":["Neonatal Hyperbilirubinemia"],"enrollment":250,"completionDate":"2027-12-31"},{"nctId":"NCT04659876","phase":"","title":"Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital","startDate":"2020-03-22","conditions":["Covid19 and Mortality"],"enrollment":445,"completionDate":"2020-12-08"},{"nctId":"NCT05100342","phase":"","title":"Prospective Validation of a Points Score System Predicting 30-day Survival","status":"RECRUITING","sponsor":"Indiana University","startDate":"2022-09-12","conditions":["Metastatic Cancer"],"enrollment":114,"completionDate":"2027-12"},{"nctId":"NCT06209489","phase":"NA","title":"White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns","status":"COMPLETED","sponsor":"Karabuk University","startDate":"2024-03-01","conditions":["Newborn Jaundice","Hyperbilirubinemia, Neonatal","Newborn Massage","Phototerapy","White Cover"],"enrollment":60,"completionDate":"2024-06-30"},{"nctId":"NCT06921330","phase":"NA","title":"White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns","status":"NOT_YET_RECRUITING","sponsor":"Karabuk University","startDate":"2026-01-01","conditions":["Newborn Jaundice","Hyperbilirubinemia, Neonatal","ABO Incompatibility","Newborn Massage","Phototherapy","White Cover"],"enrollment":60,"completionDate":"2026-03-05"},{"nctId":"NCT03471143","phase":"PHASE1,PHASE2","title":"Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-02-22","conditions":["Niemann-Pick Disease, Type C"],"enrollment":4,"completionDate":"2024-10-04"},{"nctId":"NCT07315126","phase":"","title":"Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03","conditions":["Neonatal Jaundice"],"enrollment":510,"completionDate":"2027-04"},{"nctId":"NCT07291882","phase":"","title":"Serum Hyperbilirubinemia as an Early Predictive Factor for Complicated Appendicitis: Single Center Experience","status":"COMPLETED","sponsor":"Minia University","startDate":"2024-09-01","conditions":["Appendicitis, Surgery"],"enrollment":400,"completionDate":"2025-08-20"},{"nctId":"NCT05089227","phase":"PHASE2","title":"Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-02-03","conditions":["Prolonged Anticoagulation","Venous Thromboembolic Disease","Autoimmune Hemolytic Anemia"],"enrollment":72,"completionDate":"2028-08"},{"nctId":"NCT03927833","phase":"NA","title":"Cycled Phototherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"NICHD Neonatal Research Network","startDate":"2020-07-16","conditions":["Hyper Bilirubinemia","Premature Infant"],"enrollment":1700,"completionDate":"2027-07-31"},{"nctId":"NCT06562803","phase":"NA","title":"Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-09-27","conditions":["Acute-On-Chronic Liver Failure","Sepsis"],"enrollment":60,"completionDate":"2026-10-31"},{"nctId":"NCT07110987","phase":"NA","title":"The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia","status":"RECRUITING","sponsor":"Tishreen University Hospital","startDate":"2025-06-26","conditions":["Hyperbilirubinemia, Neonatal Indirect"],"enrollment":70,"completionDate":"2027-03-01"},{"nctId":"NCT06963450","phase":"","title":"NeoSCB App for Screening Jaundice in Newborns","status":"RECRUITING","sponsor":"University College, London","startDate":"2025-09-23","conditions":["Neonatal Jaundice"],"enrollment":405,"completionDate":"2027-03-31"},{"nctId":"NCT04398680","phase":"PHASE1","title":"A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2021-04-20","conditions":["Multiple Myeloma"],"enrollment":0,"completionDate":"2025-11-04"},{"nctId":"NCT04584983","phase":"PHASE2","title":"Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-02-11","conditions":["Bilirubin Encephalopathy"],"enrollment":134,"completionDate":"2026-06-14"},{"nctId":"NCT05127044","phase":"NA","title":"Characterization of Pre-Term Neonatal Skin","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2023-10-13","conditions":["Skin Disorder"],"enrollment":44,"completionDate":"2024-08-17"},{"nctId":"NCT05687500","phase":"PHASE2","title":"Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-20","conditions":["Transient; Hypoglycemia, Neonatal","Preterm","Glibenclamide Adverse Reaction"],"enrollment":35,"completionDate":"2027-02-20"},{"nctId":"NCT05178069","phase":"PHASE2","title":"LGG Supplementation in Patients With AUD and ALD","status":"RECRUITING","sponsor":"University of Louisville","startDate":"2022-06-01","conditions":["Alcohol Use Disorder","Alcohol-associated Liver Disease"],"enrollment":60,"completionDate":"2027-02-28"},{"nctId":"NCT04546789","phase":"PHASE1","title":"Effect of Hepatic Impairment on M2951 (BTK Inhibitor) PK","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2020-09-30","conditions":["Hepatic Impairment"],"enrollment":24,"completionDate":"2021-05-16"},{"nctId":"NCT00422877","phase":"PHASE2","title":"Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract","status":"TERMINATED","sponsor":"American Regent, Inc.","startDate":"2007-01","conditions":["Cancer of the Liver"],"enrollment":13,"completionDate":"2008-03"},{"nctId":"NCT06330441","phase":"NA","title":"Pancreatic Cancer Screening in a Population at High Risk","status":"RECRUITING","sponsor":"Masaryk Memorial Cancer Institute","startDate":"2022-01-07","conditions":["Pancreatic Ductal Adenocarcinoma","Hereditary Diseases","Pancreatitis, Chronic"],"enrollment":700,"completionDate":"2028-01-06"},{"nctId":"NCT07182513","phase":"","title":"Turkish Version of the Hammersmith Neonatal Neurological Examination (HNNE)","status":"RECRUITING","sponsor":"Kahramanmaras Sutcu Imam University","startDate":"2025-08-22","conditions":["Cerebral Palsy (CP)","Infant ALL","Neurological Development","Neonatal"],"enrollment":120,"completionDate":"2026-03-15"},{"nctId":"NCT07156721","phase":"NA","title":"White Reflective Drape in Phototherapy for Neonatal Hyperbilirubinemia","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2023-10-01","conditions":["Neonatal Hyperbilirubinemia"],"enrollment":102,"completionDate":"2024-08-18"},{"nctId":"NCT06003400","phase":"NA","title":"Proof of Concept Open Label, Clinical Trial to Evaluate the Safety and Efficacy of the \"FITT\" Device in Diabetic Foot Ulcers Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tri.O Medical LTD","startDate":"2023-03-29","conditions":["Diabetic Foot Ulcer"],"enrollment":20,"completionDate":"2026-01"},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":["SLE","Lupus","Systemic Lupus Erthematosus","Systemic Lupus Erythematosus","Systemic Lupus Erythematosus (SLE)"],"enrollment":10,"completionDate":"2026-07"},{"nctId":"NCT06645158","phase":"","title":"TCB Self-Monitoring in Healthy Term and Near-Term Neonates","status":"COMPLETED","sponsor":"Neonatal-Infant Brain and Behavior Development Network","startDate":"2020-08-01","conditions":["Hyperbilirubinemia, Neonatal"],"enrollment":220950,"completionDate":"2025-07-01"},{"nctId":"NCT05557487","phase":"","title":"Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration","status":"RECRUITING","sponsor":"Gee-Chen Chang","startDate":"2022-12-15","conditions":["Lung Cancer","High-Risk Cancer","Smoking","Pollution; Exposure","Family Relations"],"enrollment":6618,"completionDate":"2028-12-31"},{"nctId":"NCT07132489","phase":"","title":"Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-01","conditions":["Myocardial Infarction","No Reflow Phenomenon"],"enrollment":114,"completionDate":"2028-12-01"},{"nctId":"NCT07144501","phase":"NA","title":"Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-09-15","conditions":["Congenital Heart Disease","Liver Dysfunction"],"enrollment":40,"completionDate":"2026-03-15"},{"nctId":"NCT07116369","phase":"","title":"Prediction of SBP in Cirrhotic Patients by Platlet Count, Na and AlBl Index.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-08","conditions":["Spontaneous Bacterial Peritonitis"],"enrollment":100,"completionDate":"2025-12"},{"nctId":"NCT07116044","phase":"","title":"Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection","status":"COMPLETED","sponsor":"University of Molise","startDate":"2023-06-15","conditions":["Evaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients"],"enrollment":160,"completionDate":"2025-07-30"},{"nctId":"NCT07098234","phase":"NA","title":"Effect of Vitamin-D as an Adjuvant to Phototherapy in Reduction of Indirect Serum Bilirubin","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2022-07-01","conditions":["Hyperbilirubinemia"],"enrollment":90,"completionDate":"2022-12-31"},{"nctId":"NCT07102836","phase":"PHASE2","title":"COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY","status":"RECRUITING","sponsor":"Quaid-e-Azam Medical College","startDate":"2025-08-07","conditions":["Indirect Hyperbilirubinemia","Neonatal"],"enrollment":110,"completionDate":"2026-05-07"},{"nctId":"NCT06236165","phase":"PHASE2","title":"Clinical Study Evaluating Efficacy, Safety and Molecular Mechanism of N-acetylcysteine Supplementation in Patients With Hepatic and Post Hepatic Jaundice","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-02-14","conditions":["Hepatic and Post Hepatic Jaundice"],"enrollment":44,"completionDate":"2025-01-22"},{"nctId":"NCT06944704","phase":"PHASE2","title":"Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-04-03","conditions":["Hepatobiliary Disorders"],"enrollment":43,"completionDate":"2025-03-19"},{"nctId":"NCT06620835","phase":"PHASE2","title":"Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib","status":"RECRUITING","sponsor":"Groupe Francais De Pneumo-Cancerologie","startDate":"2025-06-19","conditions":["NSCLC"],"enrollment":45,"completionDate":"2030-10-01"},{"nctId":"NCT07084987","phase":"NA","title":"Massage, Tub Bathing, and Sponge Bathing Effects on Neonatal Bilirubin and Comfort","status":"COMPLETED","sponsor":"Uludag University","startDate":"2021-09-01","conditions":["Neonatal Hyperbilirubinemia","Newborn Care Phototherapy"],"enrollment":120,"completionDate":"2024-08-01"},{"nctId":"NCT07080398","phase":"","title":"Accuracy of TcB Measurements During and After Phototherapy","status":"COMPLETED","sponsor":"Kanuni Sultan Suleyman Training and Research Hospital","startDate":"2024-11-01","conditions":["Neonatal Hyperbilirubinemia"],"enrollment":90,"completionDate":"2025-07-01"},{"nctId":"NCT06993220","phase":"","title":"Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients","status":"RECRUITING","sponsor":"Consorci Sanitari Integral","startDate":"2025-01-01","conditions":["Acute Heart Failure (AHF)","Congestive Heart Failure(CHF)"],"enrollment":500,"completionDate":"2027-01-01"},{"nctId":"NCT07048236","phase":"","title":"Specimen and Clinical Data Collection Plan for LDCT Screening Participants","status":"RECRUITING","sponsor":"Chung Shan Medical University","startDate":"2025-07-17","conditions":["Lung Cancer","Smoking","Family Relations"],"enrollment":12000,"completionDate":"2034-12-31"},{"nctId":"NCT03890536","phase":"","title":"Intestinal Microbiome Composition in Infants With Biliary Atresia (BA)","status":"WITHDRAWN","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2023-12","conditions":["Biliary Atresia","Intrahepatic Cholestases","Normal Controls"],"enrollment":0,"completionDate":"2032-03"},{"nctId":"NCT07038863","phase":"NA","title":"Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-09-01","conditions":["HEPATITIS C (HCV)","Hepatitis B Virus (HBV)","Hepatitis D","Hepatocellular Carcinoma (HCC)","Liver Fibrosis"],"enrollment":2000,"completionDate":"2028-05-01"},{"nctId":"NCT07030114","phase":"","title":"The Study Seeks to Determine Potential Correlations Between Ventilation and Hematological Alterations, Contributing to a Better Understanding of Its Physiological Effects and Optimizing Patient Management in Critical Care Settings.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":["Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome"],"enrollment":60,"completionDate":"2027-05"},{"nctId":"NCT07027332","phase":"","title":"Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2024-05-29","conditions":["Polycystic Ovary Syndrome","Non-Alcoholic Fatty Liver Disease"],"enrollment":36,"completionDate":"2025-03-08"},{"nctId":"NCT07010198","phase":"","title":"Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City","status":"RECRUITING","sponsor":"Zhongshan People's Hospital, Guangdong, China","startDate":"2025-03-01","conditions":["Hepatocellular Cancer (HCC)"],"enrollment":4500,"completionDate":"2028-12-31"},{"nctId":"NCT03195998","phase":"","title":"Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants","status":"COMPLETED","sponsor":"Pediatrix","startDate":"2017-06-30","conditions":["Hyperbilirubinemia"],"enrollment":166,"completionDate":"2019-02-01"},{"nctId":"NCT06956638","phase":"","title":"Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation","status":"COMPLETED","sponsor":"Nepalese Army Institute of Health Sciences","startDate":"2022-07-16","conditions":["Acute Appendicitis","Appendicitis Perforated"],"enrollment":98,"completionDate":"2025-03-12"},{"nctId":"NCT06795100","phase":"PHASE4","title":"Pharmacokinetic Study of Intravenous Lidocaine in Young and Elderly Patients","status":"RECRUITING","sponsor":"Rennes University Hospital","startDate":"2025-04-28","conditions":["Anesthesia"],"enrollment":64,"completionDate":"2027-02-01"},{"nctId":"NCT06934070","phase":"","title":"Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qiang Xu","startDate":"2025-04-03","conditions":["Hepatocellular Carcinoma (HCC)","Hepatocellular Carcinoma (HCC) Prognosis"],"enrollment":287,"completionDate":"2025-04-16"},{"nctId":"NCT06837935","phase":"NA","title":"Aluminum Foil Reflector on Phototherapy for Newborn with Jaundice","status":"NOT_YET_RECRUITING","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2025-05-01","conditions":["Newborn Jaundice"],"enrollment":160,"completionDate":"2026-12-31"},{"nctId":"NCT06894550","phase":"NA","title":"Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-04-01","conditions":["Aortic Stenosis","Altitude"],"enrollment":60,"completionDate":"2026-09-01"},{"nctId":"NCT06058910","phase":"","title":"Bilistick Point-of-care System 2.0 Bilirubin Validation","status":"COMPLETED","sponsor":"Kettering Health Network","startDate":"2024-02-01","conditions":["Neonatal Screening","Kernicterus","Newborn Jaundice","Point-of-Care Testing"],"enrollment":80,"completionDate":"2024-09-09"},{"nctId":"NCT03857646","phase":"PHASE4","title":"The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-03-02","conditions":["Prematurity"],"enrollment":66,"completionDate":"2020-06-11"},{"nctId":"NCT06849661","phase":"","title":"Do Preoperative Bilirubin Levels Affect Recovery and Hospital Stay After Sedation Anesthesia?","status":"ENROLLING_BY_INVITATION","sponsor":"Naime Yalçın","startDate":"2025-01-15","conditions":["Preoperative Biliary Drainage","Recovery Period, Anesthesia","Hospital Length of Stay"],"enrollment":360,"completionDate":"2025-10-01"},{"nctId":"NCT06819150","phase":"NA","title":"Effect of Bathing on Physiological Parameters, Skin, Bilirubin and Comfort Levels in Infants Receiving Phototherapy","status":"RECRUITING","sponsor":"Selcuk University","startDate":"2024-05-01","conditions":["Phototherapy Skin Rash"],"enrollment":60,"completionDate":"2025-03-15"},{"nctId":"NCT04986917","phase":"NA","title":"Laparoscopic Ventral Hernia Repair with Routine Defect Closure Using Su2ura® Approximation Device","status":"COMPLETED","sponsor":"Anchora Medical","startDate":"2022-01-19","conditions":["Ventral Hernia"],"enrollment":18,"completionDate":"2024-11-21"},{"nctId":"NCT05956314","phase":"PHASE1","title":"Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2023-03-06","conditions":["Punctate Palmoplantar Keratoderma Type 1","Pachyonychia Congenita"],"enrollment":18,"completionDate":"2024-11-07"},{"nctId":"NCT05435638","phase":"PHASE1","title":"Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases","status":"COMPLETED","sponsor":"Kamari Pharma Ltd","startDate":"2022-07-17","conditions":["Punctate Palmoplantar Keratoderma Type 1","Pachyonychia Congenita"],"enrollment":14,"completionDate":"2024-09-05"},{"nctId":"NCT04218318","phase":"NA","title":"Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn","status":"RECRUITING","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2019-10-01","conditions":["Hemolytic Disease of Newborn","Neonatal Hyperbilirubinemia"],"enrollment":84,"completionDate":"2027-01-01"},{"nctId":"NCT04304651","phase":"NA","title":"Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2020-09-08","conditions":["Embolism and Thrombosis"],"enrollment":1276,"completionDate":"2030-09-08"},{"nctId":"NCT05920785","phase":"","title":"Clinical and Metabolic, Immunological and Microbiological Characteristics of Obese Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Samara State Medical University","startDate":"2023-04-02","conditions":["Obesity"],"enrollment":50,"completionDate":"2026-04-02"},{"nctId":"NCT05428631","phase":"NA","title":"Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2022-08-26","conditions":["Heart Failure","Renal Insufficiency"],"enrollment":10,"completionDate":"2027-08-26"},{"nctId":"NCT06289868","phase":"","title":"Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23)","status":"COMPLETED","sponsor":"Beckman Coulter, Inc.","startDate":"2024-02-27","conditions":["HAV"],"enrollment":1409,"completionDate":"2024-08-29"},{"nctId":"NCT03805165","phase":"","title":"Associations of Nighttime Light Exposure During Pregnancy With Neonatal Jaundice：a Multi-centre Prospective Study in China","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2019-02-01","conditions":["Jaundice, Neonatal"],"enrollment":2977,"completionDate":"2019-12-31"},{"nctId":"NCT06708728","phase":"","title":"Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2024-12","conditions":["Hemolytic Anemia"],"enrollment":60,"completionDate":"2025-06"},{"nctId":"NCT05497830","phase":"NA","title":"Machine Learning for Risk Stratification in the Emergency Department (MARS-ED)","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2022-09-12","conditions":["Acute Pain","Emergencies"],"enrollment":1300,"completionDate":"2024-11-01"},{"nctId":"NCT06672406","phase":"NA","title":"Effect of Probiotic Lacobacillus Reuterii on Serum Bilirubin Levels in Preterm Infants","status":"COMPLETED","sponsor":"Hasanuddin University","startDate":"2024-01-01","conditions":["Hyperbilirubinemia, Neonatal"],"enrollment":40,"completionDate":"2024-10-21"},{"nctId":"NCT04860154","phase":"NA","title":"Photodynamic Therapy for Cholangiocarcinoma","status":"COMPLETED","sponsor":"Hepatopancreatobiliary Surgery Institute of Gansu Province","startDate":"2021-04-17","conditions":["Cholangiocarcinoma Non-resectable"],"enrollment":86,"completionDate":"2024-11-19"},{"nctId":"NCT03598465","phase":"","title":"Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2019-03-05","conditions":["Post-hepatectomy Liver Failure"],"enrollment":591,"completionDate":"2024-10-01"},{"nctId":"NCT06676410","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2023-07-20","conditions":["HIV","HIV Infection"],"enrollment":40,"completionDate":"2024-12"},{"nctId":"NCT05356273","phase":"NA","title":"The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2021-10-01","conditions":["Hyperbilirubinemia, Neonatal"],"enrollment":61,"completionDate":"2022-01-01"},{"nctId":"NCT04962113","phase":"NA","title":"Effect of Tub Bathing on Skin and Bilirubin Levels in Infants Undergoing Tunnel and LED of Phototherapy","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","startDate":"2019-11-01","conditions":["Newborn Jaundice"],"enrollment":140,"completionDate":"2020-09-01"},{"nctId":"NCT06614114","phase":"","title":"Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding","status":"RECRUITING","sponsor":"Assiut University","startDate":"2024-09-24","conditions":["Prediction of Variceal Bleeding"],"enrollment":48,"completionDate":"2025-12-01"},{"nctId":"NCT03814031","phase":"","title":"Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2018-02-20","conditions":["Postoperative Graft Function"],"enrollment":97,"completionDate":"2019-12-31"},{"nctId":"NCT05521607","phase":"NA","title":"Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice (Chicago)","status":"RECRUITING","sponsor":"Picterus AS","startDate":"2023-01-06","conditions":["Neonatal Jaundice"],"enrollment":250,"completionDate":"2025-06-15"},{"nctId":"NCT06603753","phase":"","title":"Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).","status":"NOT_YET_RECRUITING","sponsor":"alaa aboelhassan mohamed aboelhassan","startDate":"2025-01-01","conditions":["Hyperbilirubinemia, Neonatal"],"enrollment":80,"completionDate":"2026-07-01"},{"nctId":"NCT06602986","phase":"NA","title":"Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Pak Emirates Military Hospital","startDate":"2024-10-12","conditions":["HCC - Hepatocellular Carcinoma"],"enrollment":96,"completionDate":"2025-07-13"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral"},"crossReferences":{"UNII":"2P3VWU3H10","SPL_ID":"9cfee475-afb6-479b-a552-240f97fb29a7","chemblId":"CHEMBL2074720"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"","companyName":"BioActive Nutritional, Inc.","relationship":"Original Developer"}],"publicationCount":50910,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"originalDeveloper":"BioActive Nutritional, Inc.","recentPublications":[{"date":"2025","pmid":"41909880","title":"Low incidence of cytolysin-positive E. faecalis and no correlation to survival in Danish patients with alcohol-associated hepatitis: A prospective cohort study.","journal":"Gut microbes reports"},{"date":"2026","pmid":"41909607","title":"Prognostic Outcomes by Ishak Fibrosis Score Grouping in Biliary Atresia After Kasai Surgery.","journal":"International journal of general medicine"},{"date":"2026","pmid":"41909593","title":"Development and Validation of an Explainable Machine Learning Model for Predicting Repeat Catheter Ablation for Atrial Fibrillation: A Single-Center Retrospective Cohort Study.","journal":"International journal of general medicine"},{"date":"2026 May-Jun","pmid":"41908670","title":"Prognostic Significance of Serum Ferritin in Decompensated Cirrhosis: Insights from a Prospective Analysis.","journal":"Journal of clinical and experimental hepatology"},{"date":"2025","pmid":"41908015","title":"Effect of dexmedetomidine, lignocaine and combination infusion for postoperative outcomes in abdominal surgery.","journal":"Bioinformation"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"BioActive Nutritional, Inc.","companyId":"bioactive-nutritional-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:30:15.322973+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}